In WT cells, S100a8 production is generally suppressed upon TLR4 activation, analogous to clinical studies which show that circulating calprotectin levels remain low in majority of the COVID-19 patients who are asymptomatic or have mild symptoms. The gene discussed is S100A8; the disease is COVID-19.